Assessing and treating the microbiome – a case-based and clinical approach

Presented by Linda Toresson, DVM, PhD, Swedish specialist in small animal internal medicine

Continuing education questionnaire

CE credit: 1

Name

Questions

1. True or False. In a 2021 study by Werner et al., “Diagnostic value of fecal cultures in dogs with chronic diarrhea,” in 2/3 laboratories, more abnormal cultures were reported in dogs with chronic diarrhea than healthy dogs. *
2. Regarding the dysbiosis index, dysbiosis is defined as healthy, mild or severe, respectively, by the following numerical values *
3. What percentage of intestinal microbiome species are able to be identified with conventional culture modalities? *
4. In a 2002 study by Engvall et al., “Isolation and identification of thermophilic Campylobacter species in faecal samples from Swedish dogs,” 39%–76% of healthy dogs under 2y of age shed Campylobacter spp. *
5. Which of the following statements regarding healthy dogs as compared with those with dysbiosis (in both acute and chronic gastroenteritis) is correct? *
6. Which of the following regarding the benefits of SCFAs is true when it comes to microbial gastrointestinal health? *
7. Excessive primary bile acids in the colon can result in diarrhea via what mechanism? *
8. In healthy dogs, what effect does metronidazole therapy have on the intestinal microbiome? *
9. Which of the following are tools that affect the microbiotia in chronic enteritis? *
10. In a 2020 article by Cerquetella et al., “Proposal for rational antibacterial use in the diagnosis and treatment of dogs with chronic diarrhoea,” which of the following treatment was recommended last (with some exceptions)? *